23andMe, DNA
Digest more
Top News
Impacts
“What we’re witnessing with 23andMe is a stark wake-up call for data privacy,” said Adrianus Warmenhoven, a cybersecurity expert at NordVPN.
From Associated Press News
Last week, the genetics company filed for bankruptcy and will sell its trove of user-submitted DNA to the highest or best bidder, the company said in an open letter to customers about the bankruptcy p...
From HuffPost
Read more on News Digest
Alain Sherter is a senior managing editor with CBS News. He covers business, economics, money and workplace issues for CBS MoneyWatch. 23andMe, a formerly high-flying genetic testing company ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Max Eddy Max Eddy is a writer who has covered privacy and security ...
23andMe filed for Chapter 11 bankruptcy on Sunday. The company says no changes will be made to how it stores, manages or protects customer data up until the sale of its assets is finalized.
23andMe might have filed for bankruptcy, but the transformation it brought to health care over nearly two decades is irreversible. I’m a physician, scientist, and advocate for public health.
So it wasn't a big surprise that after the failure of a last-ditch bid by the CEO to take the company private, 23andMe ultimately filed for Chapter 11 bankruptcy protection in late March ...
With Sunday’s announcement by genetic testing firm 23andMe that it has filed for bankruptcy, customers of the site may be wondering what will happen to their data and what, if anything ...
Customers fear their data may be sold to a new company. Over the weekend, genetic testing and biotechnology company 23andMe filed for Chapter 11 bankruptcy. Founded in 2006, the company became ...
"23andMe's bankruptcy announcement is concerning and I am urging New Yorkers to take action to safeguard their data," James said. "New Yorkers can follow instructions offered by my office to ...
23andMe files for bankruptcy, says data privacy will be ‘important consideration’ if company is sold
23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs. San Francisco-based ...